“Long-Term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience”. 2025. Journal of Kidney Cancer 12 (3): 25-31. https://doi.org/10.15586/jkcvhl.v12i3.425.